# FDA 483 - Jbc Corp - May 24, 2019

Source: https://www.globalkeysolutions.net/records/483/jbc-corp/5006690a-5e1d-4bdb-87b4-45fd408648a8

> FDA 483 for Jbc Corp on May 24, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Jbc Corp
- Inspection Date: 2019-05-24
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - East II
- Summary: Jbc Corp, a drug repacker in Virginia Beach, VA, was cited with five observations during an FDA inspection from May 20-24, 2019. The inspection revealed significant deficiencies in quality control unit procedures, environmental controls, batch record documentation, employee training, and complaint handling, indicating a lack of fundamental GMP compliance. These issues raise concerns about the identity, strength, quality, and purity of drug products assembled into medical kits.

## Related Documents

- [483 - 2019-02-08](https://www.globalkeysolutions.net/records/483/jbc-corp/ac1a9167-f139-4ee3-b5e0-01161dce0c2f)

## Related Officers

- [Pharmacy Intern/Certified Pharmacy Technician](https://www.globalkeysolutions.net/people/david-a-oluwo/209d60bd-27d8-487b-8249-1c6e44fcc317)

Company: https://www.globalkeysolutions.net/companies/jbc-corp/beced889-92ee-45ae-86a9-0e7d0decc75e

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-east-ii/a9ab7e08-db36-4350-a7d7-6a61dc61250e